Marco A Prado

Title: The Innovative Contributions of Marco A Prado

Introduction

Marco A Prado is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of neuroscience, particularly in the study of cholinergic dysfunction. His work focuses on developing models that can help evaluate cognitive enhancers and treatments for myasthenia.

Latest Patents

Marco A Prado holds a patent titled "Mouse model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myasthenia." This patent describes recombinant non-human mammals that exhibit reduced or no expression of vesicular acetylcholine transporter protein (VAChT) compared to their wild-type counterparts. These mammals may demonstrate impaired performance in object and social recognition, neuromuscular performance, and alterations in autonomic nervous system function. The patent also outlines methods for screening compounds for cholinergic activity and their potential in treating cholinergic neurotransmission disorders. Additionally, it provides details on nerve cells isolated from these mammals, which can be used in vitro for screening candidate compounds.

Career Highlights

Throughout his career, Marco A Prado has worked with prestigious institutions such as Duke University and Universidade Federal de Minas Gerais. His research has contributed to a deeper understanding of cholinergic neurotransmission and its implications for cognitive health.

Collaborations

Marco has collaborated with esteemed colleagues, including Marc G Caron and Vania F Prado. These partnerships have further enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Marco A Prado's innovative work in developing models for cholinergic dysfunction has the potential to advance the understanding and treatment of cognitive disorders. His contributions to neuroscience are invaluable and continue to inspire further research in the field.